Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD) [Phase 2]

View source ↗

Summary

Phase 2 exploratory study sponsored by Yale University to test whether manipulating the immune system can prevent the emergence of synucleinopathy-related manif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: REM Sleep Behavior Disorder | Phase 2 | Status: NOT_YET_RECRUITING